reach usupdatesblogsfieldscommon questions
archiveindexconversationsmission

Avalo Therapeutics Announces Key Developments and Financial Overview for Q1 2025

May 12, 2025 - 14:37

Avalo Therapeutics Announces Key Developments and Financial Overview for Q1 2025

Mike Heffernan has been appointed as the new Chairman of the Board at Avalo Therapeutics, marking a significant leadership change for the company. In addition to this appointment, the company is anticipating the release of topline data from its Phase 2 LOTUS trial for AVTX-009, a treatment aimed at addressing hidradenitis suppurativa, with results expected in 2026.

As of March 31, 2025, Avalo reported a robust cash position of approximately $125 million, which is projected to provide sufficient financial runway into 2027. This funding will allow the company to continue its focus on developing innovative therapies for immune dysregulation, with the potential to extend operations into 2028 if necessary.

These updates reflect Avalo's commitment to advancing its clinical programs and enhancing shareholder value as it navigates the complexities of the biotechnology landscape. The leadership transition and solid financial standing position the company for future growth and success in the coming years.


MORE NEWS

Kimberly Goes to Business School, part 2: Supporting the work

April 7, 2026 - 06:59

Kimberly Goes to Business School, part 2: Supporting the work

The journey of `Kimberly Goes to Business School` continues with a critical lesson in the realities of workplace technology. A recent experiment in adopting a new scheduling model has served as a...

Mass. business confidence slips back into pessimistic territory

April 6, 2026 - 17:14

Mass. business confidence slips back into pessimistic territory

After a brief period of optimism, the outlook among Massachusetts employers has soured once again. The latest monthly index tracking business sentiment has fallen, slipping back into pessimistic...

A Look At Brookfield Business Partners (TSX:BBUC) Valuation After Its Recent 3.6% One Day Move

April 6, 2026 - 03:12

A Look At Brookfield Business Partners (TSX:BBUC) Valuation After Its Recent 3.6% One Day Move

Brookfield Business Partners (TSX:BBUC) has drawn significant investor attention following a notable single-day surge of 3.6%, closing at CA$48.00. This move prompts a closer examination of the...

Nampa City Council greenlights alcohol sales at two businesses

April 5, 2026 - 20:13

Nampa City Council greenlights alcohol sales at two businesses

The Nampa City Council has granted approval for alcohol sales at two establishments within the city. The decisions were finalized during the council`s most recent meeting, allowing both businesses...

read all news
suggestionsreach usupdatesblogsfields

Copyright © 2026 Groevo.com

Founded by: Lily Pacheco

common questionsarchiveindexconversationsmission
privacy policycookie policyuser agreement